Cargando…
Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is characterized by the deposition of amyloid-β (Aβ) in brain parenchyma and cerebral blood vessels as cerebral amyloid angiopathy (CAA). Clusterin, a chaperon protein associated with Aβ aggregation, toxicity and transport through blood–brain barrier, may play a...
Autores principales: | Qi, Xue-Mei, Wang, Cheng, Chu, Xing-Kun, Li, Gen, Ma, Jian-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785859/ https://www.ncbi.nlm.nih.gov/pubmed/29370749 http://dx.doi.org/10.1186/s12868-018-0402-7 |
Ejemplares similares
-
Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice
por: Patel, Sagar, et al.
Publicado: (2014) -
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
por: Wojtas, Aleksandra M., et al.
Publicado: (2020) -
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
por: Foster, Evangeline M., et al.
Publicado: (2019) -
Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models
por: Goñi, Fernando, et al.
Publicado: (2013) -
Young blood plasma reduces Alzheimer’s disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice
por: Zhao, Ying, et al.
Publicado: (2020)